Systematic review with meta‐analysis

Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases.

Influence of food and lifestyle

Influence of food and lifestyle on the risk of developing inflammatory bowel disease.

Inflammatory bowel disease in pregnancy

Inflammatory bowel disease in pregnancy: a population‐based study of prevalence and pregnancy outcomes.